COVID-19: Do not forget the host in treating this disease

by Jeff Hansen,University of Alabama at BirminghamRandy Cron, M.D., Ph.D. Credit: University of Alabama at BirminghamRandy Cron, M.D., Ph.D., is an expert in a dangerous immune reaction to some

Updated on: April 12,2024 20

COVID-19: Do not forget the host in treating this disease

by Jeff Hansen,University of Alabama at BirminghamRandy Cron, M.D., Ph.D. Credit: University of Alabama at BirminghamRandy Cron, M.D., Ph.D., is an expert in a dangerous immune reaction to some

Updated on:April 12,2024 20

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on: April 10,2024 16

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on:April 10,2024 16

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on: March 25,2024 11

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on:March 25,2024 11

Study shows narrative conversion messages boost attitudes about COVID vaccinations among unvaccinated adults

by Mike Krings,University of KansasCredit: CC0 Public DomainPublic health communicators have tried numerous methods to encourage people to accept COVID-19 vaccinations and boosters. And while so

Updated on: March 27,2024 0

Study shows narrative conversion messages boost attitudes about COVID vaccinations among unvaccinated adults

by Mike Krings,University of KansasCredit: CC0 Public DomainPublic health communicators have tried numerous methods to encourage people to accept COVID-19 vaccinations and boosters. And while so

Updated on:March 27,2024 0

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on: April 01,2024 20

Type 1 IFNs may mediate Zika pregnancy complications

(HealthDay)—Type 1 interferons (IFNs) may mediate pregnancy complications in the context of congenital Zika virus (ZIKV) infection, according to a study published in the Jan. 5 issue ofScience I

Updated on:April 01,2024 20

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on: April 16,2024 13

HIV-infected cells persist in CSF in individuals on long-term ART

(HealthDay)—About half of HIV-positive individuals on long-term antiretroviral therapy (ART) have HIV-infected cells in their cerebrospinal fluid (CSF), according to a study published online July 15 i

Updated on:April 16,2024 13

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on: March 26,2024 11

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on:March 26,2024 11

Internal tremors: Adding to the list of long COVID symptoms

by Freda Kreier,Yale UniversityMost important symptoms for differentiating between participants with and without internal tremors. Credit:The American Journal of Medicine(2024). DOI:

Updated on: September 10,2024 0

Internal tremors: Adding to the list of long COVID symptoms

by Freda Kreier,Yale UniversityMost important symptoms for differentiating between participants with and without internal tremors. Credit:The American Journal of Medicine(2024). DOI:

Updated on:September 10,2024 0

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on: March 20,2024 11

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on:March 20,2024 11

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on: April 12,2024 11

Will COVID-19 vaccines need to be adapted regularly?

by Charité - Universitätsmedizin BerlinJust like thephylogenetic tree of the influenza virus subtype H3N2 (right), the phylogenetic tree of the ‘common cold’ coronavirus 229E (left) shows a

Updated on:April 12,2024 11

Lolamicin: A Revolutionary Antibiotic Targeting Gram-Negative Bacteria Without Disrupting the Gut Microbiome

Updated on: June 01,2024 0

Lolamicin: A Revolutionary Antibiotic Targeting Gram-Negative Bacteria Without Disrupting the Gut Microbiome

Updated on:June 01,2024 0

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on: May 05,2024 18

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on:May 05,2024 18